Back to results
US 12,715,894 B2Granted
Triptolide conjugates and uses thereof
AssigneesReyoung Corporation, Reyoung Drug Discovery Co., LTD.
InventorsFrank Shujie Hou, Jian Xue, Yushan Zhao, Dezu Miao
Life of this patent
Estimating the term…
Abstract
This disclosure provides triptolide-conjugates, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, as well methods of using such compounds in the treatment of conditions/diseases, such as those relating to cancer, immunomodulation and/or inflammation.
Claims13
A compound of Formula I, or an enantiomer, an enantiomeric mixture, a diastereomer, a diastereomeric mixture, or a pharmaceutically acceptable salt thereof:
- wherein
- m1, m2, n1, n2 are each independently 0-15;
- R1, R2, and R3 each independently OH, H, halo, unsubstituted or substituted C1-C10 alkyl, unsubstituted or substituted C3-C10 cycloalkyl, unsubstituted or substituted C1-C10 acyl, unsubstituted or substituted C1-C10 carboxyl ester, unsubstituted or substituted C1-C10 alkyl ketone, or unsubstituted or substituted C1-C10 alkyl ether;
- M1 is selected from a bond, —C(═O)—, —OPO2—, —SO2—, —NH(CO)—, —(CO)NH—, —CH2OPO2—,
- —CH2—O—C(═O)—, and —CH2O—;
- M2 is selected from C and Si;
- X1, X2, X3, X4, and X5 are each independently a bond, —C(═O)—, (C═O)-L1-(C═O), (C═O)-L1, L1-(C═O), O(CO), (CO)O, O, S, S—S, Se—Se—, NH, NR, NH(CO), (CO)NH, L2-NH(CO), NH(CO)-L2, L2-(CO)NH, —(CO)NH-L2, (CO)NH-L2-NH(CO), NR-L2-NR, L2-O, O-L2, unsubstituted or substituted C1-C10 alkylene, unsubstituted or substituted C3-C10 cycloalkylene, unsubstituted or substituted arylene, unsubstituted or substituted heteroarylene, unsubstituted or substituted C1-C10 heterocyclylene, or unsubstituted or substituted peptide comprising 1-10 natural amino acids;
- each L1 is each independently unsubstituted or substituted arylene, unsubstituted or substituted heteroarylene, unsubstituted or substituted C1-C10 heterocyclylene;
- each L2 is each independently unsubstituted or substituted C1-C10 alkylene;
- each R is independently unsubstituted or substituted C1-C10 alkyl, unsubstituted or substituted C3-C10 cycloalkyl, unsubstituted or substituted C1-C10 acyl, unsubstituted or substituted C1-C10 carboxyl ester, unsubstituted or substituted C1-C10 alkyl ketone, or unsubstituted or substituted C1-C10 alkyl ether, unsubstituted or substituted aryl, unsubstituted or substituted heteroaryl, or unsubstituted or substituted C1-C10 heterocycyl;
- and
- X5 is attached to any one of R4, R5, R6, R7, and R8;
- the remaining R4, R5, R6, R7, and R8 that are not attached to X5 are each independently H, OH, O(CO)NH2, halo, NH(C1-C10 acyl), unsubstituted or substituted O(C1-C10 alkyl), unsubstituted or substituted O(C3-C10 cycloalkyl), unsubstituted or substituted O(C1-C10 acyl), unsubstituted or substituted C1-C10 carboxyl ester, unsubstituted or substituted C1-C10 alkyl ketone, or unsubstituted or substituted C1-C10 alkyl ether, unsubstituted or substituted aryl, unsubstituted or substituted heteroaryl, unsubstituted or substituted C1-C10 heterocycyl, unsubstituted or substituted peptide comprising 1-10 amino acids, or forms a glycosidic bond with a natural monosaccharide.
10 more elements
Dependencies are inferred from the claim text.